Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points

Summary: Neutrophils are the largest population of leucocytes and are among the first cells of the innate immune system to fight against intruding pathogens. In patients with cirrhosis, neutrophils exhibit altered functionality, including changes in phagocytic ability, bacterial killing, chemotaxis,...

Full description

Bibliographic Details
Main Authors: Irina Balazs, Vanessa Stadlbauer
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555923002021
_version_ 1797647826050613248
author Irina Balazs
Vanessa Stadlbauer
author_facet Irina Balazs
Vanessa Stadlbauer
author_sort Irina Balazs
collection DOAJ
description Summary: Neutrophils are the largest population of leucocytes and are among the first cells of the innate immune system to fight against intruding pathogens. In patients with cirrhosis, neutrophils exhibit altered functionality, including changes in phagocytic ability, bacterial killing, chemotaxis, degranulation, reactive oxygen species production and NET (neutrophil extracellular trap) formation. This results in their inability to mount an adequate antibacterial response and protect the individual from infection. Prognosis and survival in patients with cirrhosis are greatly influenced by the development of infectious complications. Multidrug-resistant bacterial infections in patients with cirrhosis are currently a growing problem worldwide; therefore, alternative methods for the prevention and treatment of bacterial infections in cirrhosis are urgently needed. The prevention and treatment of neutrophil dysfunction could be a potential way to protect patients from bacterial infections. However, the reasons for changes in neutrophil function in cirrhosis are still not completely understood, which limits the development of efficient therapeutic strategies. Both cellular and serum factors have been proposed to contribute to the functional impairment of neutrophils. Herein, we review the current knowledge on features and proposed causes of neutrophil dysfunction in cirrhosis, with a focus on current knowledge gaps and limitations, as well as opportunities for future investigations in this field.
first_indexed 2024-03-11T15:22:08Z
format Article
id doaj.art-78ec796cf64147bbb4d8a1cc71b676f2
institution Directory Open Access Journal
issn 2589-5559
language English
last_indexed 2024-03-11T15:22:08Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series JHEP Reports
spelling doaj.art-78ec796cf64147bbb4d8a1cc71b676f22023-10-28T05:09:32ZengElsevierJHEP Reports2589-55592023-11-01511100871Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey pointsIrina Balazs0Vanessa Stadlbauer1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria; Center for Biomarker Research in Medicine (CBmed), Graz, AustriaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria; Center for Biomarker Research in Medicine (CBmed), Graz, Austria; Corresponding author. Address: Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria; Tel.: +43/316/385 82282.Summary: Neutrophils are the largest population of leucocytes and are among the first cells of the innate immune system to fight against intruding pathogens. In patients with cirrhosis, neutrophils exhibit altered functionality, including changes in phagocytic ability, bacterial killing, chemotaxis, degranulation, reactive oxygen species production and NET (neutrophil extracellular trap) formation. This results in their inability to mount an adequate antibacterial response and protect the individual from infection. Prognosis and survival in patients with cirrhosis are greatly influenced by the development of infectious complications. Multidrug-resistant bacterial infections in patients with cirrhosis are currently a growing problem worldwide; therefore, alternative methods for the prevention and treatment of bacterial infections in cirrhosis are urgently needed. The prevention and treatment of neutrophil dysfunction could be a potential way to protect patients from bacterial infections. However, the reasons for changes in neutrophil function in cirrhosis are still not completely understood, which limits the development of efficient therapeutic strategies. Both cellular and serum factors have been proposed to contribute to the functional impairment of neutrophils. Herein, we review the current knowledge on features and proposed causes of neutrophil dysfunction in cirrhosis, with a focus on current knowledge gaps and limitations, as well as opportunities for future investigations in this field.http://www.sciencedirect.com/science/article/pii/S2589555923002021neutrophilscirrhosisphagocytosisROSchemotaxisNETs
spellingShingle Irina Balazs
Vanessa Stadlbauer
Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
JHEP Reports
neutrophils
cirrhosis
phagocytosis
ROS
chemotaxis
NETs
title Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
title_full Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
title_fullStr Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
title_full_unstemmed Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
title_short Circulating neutrophil anti-pathogen dysfunction in cirrhosisKey points
title_sort circulating neutrophil anti pathogen dysfunction in cirrhosiskey points
topic neutrophils
cirrhosis
phagocytosis
ROS
chemotaxis
NETs
url http://www.sciencedirect.com/science/article/pii/S2589555923002021
work_keys_str_mv AT irinabalazs circulatingneutrophilantipathogendysfunctionincirrhosiskeypoints
AT vanessastadlbauer circulatingneutrophilantipathogendysfunctionincirrhosiskeypoints